Meet SHL at 2016 PDA Universe of Pre-filled Syringes & Injection Devices

Pressrelease 0930 News 800x480

At this year’s PDA Universe of Pre-filled Syringes & Injection Devices, SHL will be showcasing both new technologies and time-tested solutions at two locations – Booth #411 and Table Top #1.

As a forward-looking company with extensive knowledge and experience in the area of drug delivery devices, SHL delivers solutions for today on the path to tomorrow.

A prime example of this is the innovative autoinjector platform – Molly®. Molly® plays a central role to both SHL and our biotechnology/pharmaceutical partners with its patient-friendly design and inherent flexibility, meeting the tough requirements of an innovative autoinjector. In addition to Molly®, a wide range of SHL devices will be available for demonstration. SHL representatives will be happy to discuss these devices along with the other services and capabilities available through our comprehensive network, including development, manufacturing, and commercialization solutions.

At the conference, Markus Bauss, Managing Director of SHL Connect, will provide a presentation on the topic of “Connectivity in Drug Delivery & Smart Administration.” Here, SHL will present pioneering technological solutions and new partnerships and Joint Ventures in areas of digital health, connected technology, and therapy management at the Table Top location.

The conference and exhibition will take place on October 17-18, 2016 at the Hyatt Regency Huntington Beach Resort and Spa, Huntington Beach, California. Visit us at Booth #411 and Table Top #1 to learn more about the Molly Family and other innovative autoinjector devices, to find out about our Connectivity solutions and to share ideas about the latest trends in the industry.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News